Login / Signup

Life under the CABOSUN: Cabozantinib improves quality-adjusted survival in comparison with sunitinib.

Jeanny B Aragon-ChingRavi A Madan
Published in: Cancer (2020)
Keyphrases
  • metastatic renal cell carcinoma
  • renal cell carcinoma
  • free survival
  • quality improvement